Global CGT Drugs Market Research Report 2026(Status and Outlook)
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global CGT Drugs market size was estimated at USD 4815.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CGT Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CGT Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CGT Drugs market.
Global CGT Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Janssen Biotech
Celgene Corporation
Juno Therapeutics
Kite Pharma
Novartis
Spark Therapeutics
Amgen
Bluebird Bio
GSK
Orchard Therapeutics
Sequoia
Fosun Kite Biotechnology
Sunway Biotech
SiBiono
Market Segmentation (by Type)
CAR-T Therapy
Viral Vector Therapy
Stem Cell Therapy
Oncolytic Virus Therapy
Market Segmentation (by Application)
Rare Disease
Tumor Disease
Eye Disease
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CGT Drugs Market
Overview of the regional outlook of the CGT Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CGT Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CGT Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global CGT Drugs market size was estimated at USD 4815.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 6.30% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global CGT Drugs market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global CGT Drugs market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the CGT Drugs market.
Global CGT Drugs Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Janssen Biotech
Celgene Corporation
Juno Therapeutics
Kite Pharma
Novartis
Spark Therapeutics
Amgen
Bluebird Bio
GSK
Orchard Therapeutics
Sequoia
Fosun Kite Biotechnology
Sunway Biotech
SiBiono
Market Segmentation (by Type)
CAR-T Therapy
Viral Vector Therapy
Stem Cell Therapy
Oncolytic Virus Therapy
Market Segmentation (by Application)
Rare Disease
Tumor Disease
Eye Disease
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CGT Drugs Market
Overview of the regional outlook of the CGT Drugs Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CGT Drugs Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of CGT Drugs, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CGT Drugs
1.2 Key Market Segments
1.2.1 CGT Drugs Segment by Type
1.2.2 CGT Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CGT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CGT Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CGT Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CGT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CGT Drugs Product Life Cycle
3.3 Global CGT Drugs Sales by Manufacturers (2020-2025)
3.4 Global CGT Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 CGT Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CGT Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CGT Drugs Market Competitive Situation and Trends
3.8.1 CGT Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest CGT Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CGT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 CGT Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CGT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CGT Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CGT Drugs Market
5.7 ESG Ratings of Leading Companies
6 CGT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CGT Drugs Sales Market Share by Type (2020-2025)
6.3 Global CGT Drugs Market Size by Type (2020-2025)
6.4 Global CGT Drugs Price by Type (2020-2025)
7 CGT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CGT Drugs Market Sales by Application (2020-2025)
7.3 Global CGT Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global CGT Drugs Sales Growth Rate by Application (2020-2025)
8 CGT DRUGS MARKET SALES BY REGION
8.1 Global CGT Drugs Sales by Region
8.1.1 Global CGT Drugs Sales by Region
8.1.2 Global CGT Drugs Sales Market Share by Region
8.2 Global CGT Drugs Market Size by Region
8.2.1 Global CGT Drugs Market Size by Region
8.2.2 Global CGT Drugs Market Size by Region
8.3 North America
8.3.1 North America CGT Drugs Sales by Country
8.3.2 North America CGT Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CGT Drugs Sales by Country
8.4.2 Europe CGT Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CGT Drugs Sales by Region
8.5.2 Asia Pacific CGT Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CGT Drugs Sales by Country
8.6.2 South America CGT Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CGT Drugs Sales by Region
8.7.2 Middle East and Africa CGT Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CGT DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of CGT Drugs by Region(2020-2025)
9.2 Global CGT Drugs Revenue Market Share by Region (2020-2025)
9.3 Global CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CGT Drugs Production
9.4.1 North America CGT Drugs Production Growth Rate (2020-2025)
9.4.2 North America CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CGT Drugs Production
9.5.1 Europe CGT Drugs Production Growth Rate (2020-2025)
9.5.2 Europe CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CGT Drugs Production (2020-2025)
9.6.1 Japan CGT Drugs Production Growth Rate (2020-2025)
9.6.2 Japan CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CGT Drugs Production (2020-2025)
9.7.1 China CGT Drugs Production Growth Rate (2020-2025)
9.7.2 China CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Janssen Biotech
10.1.1 Janssen Biotech Basic Information
10.1.2 Janssen Biotech CGT Drugs Product Overview
10.1.3 Janssen Biotech CGT Drugs Product Market Performance
10.1.4 Janssen Biotech Business Overview
10.1.5 Janssen Biotech SWOT Analysis
10.1.6 Janssen Biotech Recent Developments
10.2 Celgene Corporation
10.2.1 Celgene Corporation Basic Information
10.2.2 Celgene Corporation CGT Drugs Product Overview
10.2.3 Celgene Corporation CGT Drugs Product Market Performance
10.2.4 Celgene Corporation Business Overview
10.2.5 Celgene Corporation SWOT Analysis
10.2.6 Celgene Corporation Recent Developments
10.3 Juno Therapeutics
10.3.1 Juno Therapeutics Basic Information
10.3.2 Juno Therapeutics CGT Drugs Product Overview
10.3.3 Juno Therapeutics CGT Drugs Product Market Performance
10.3.4 Juno Therapeutics Business Overview
10.3.5 Juno Therapeutics SWOT Analysis
10.3.6 Juno Therapeutics Recent Developments
10.4 Kite Pharma
10.4.1 Kite Pharma Basic Information
10.4.2 Kite Pharma CGT Drugs Product Overview
10.4.3 Kite Pharma CGT Drugs Product Market Performance
10.4.4 Kite Pharma Business Overview
10.4.5 Kite Pharma Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis CGT Drugs Product Overview
10.5.3 Novartis CGT Drugs Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Spark Therapeutics
10.6.1 Spark Therapeutics Basic Information
10.6.2 Spark Therapeutics CGT Drugs Product Overview
10.6.3 Spark Therapeutics CGT Drugs Product Market Performance
10.6.4 Spark Therapeutics Business Overview
10.6.5 Spark Therapeutics Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen CGT Drugs Product Overview
10.7.3 Amgen CGT Drugs Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 Bluebird Bio
10.8.1 Bluebird Bio Basic Information
10.8.2 Bluebird Bio CGT Drugs Product Overview
10.8.3 Bluebird Bio CGT Drugs Product Market Performance
10.8.4 Bluebird Bio Business Overview
10.8.5 Bluebird Bio Recent Developments
10.9 GSK
10.9.1 GSK Basic Information
10.9.2 GSK CGT Drugs Product Overview
10.9.3 GSK CGT Drugs Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 Orchard Therapeutics
10.10.1 Orchard Therapeutics Basic Information
10.10.2 Orchard Therapeutics CGT Drugs Product Overview
10.10.3 Orchard Therapeutics CGT Drugs Product Market Performance
10.10.4 Orchard Therapeutics Business Overview
10.10.5 Orchard Therapeutics Recent Developments
10.11 Sequoia
10.11.1 Sequoia Basic Information
10.11.2 Sequoia CGT Drugs Product Overview
10.11.3 Sequoia CGT Drugs Product Market Performance
10.11.4 Sequoia Business Overview
10.11.5 Sequoia Recent Developments
10.12 Fosun Kite Biotechnology
10.12.1 Fosun Kite Biotechnology Basic Information
10.12.2 Fosun Kite Biotechnology CGT Drugs Product Overview
10.12.3 Fosun Kite Biotechnology CGT Drugs Product Market Performance
10.12.4 Fosun Kite Biotechnology Business Overview
10.12.5 Fosun Kite Biotechnology Recent Developments
10.13 Sunway Biotech
10.13.1 Sunway Biotech Basic Information
10.13.2 Sunway Biotech CGT Drugs Product Overview
10.13.3 Sunway Biotech CGT Drugs Product Market Performance
10.13.4 Sunway Biotech Business Overview
10.13.5 Sunway Biotech Recent Developments
10.14 SiBiono
10.14.1 SiBiono Basic Information
10.14.2 SiBiono CGT Drugs Product Overview
10.14.3 SiBiono CGT Drugs Product Market Performance
10.14.4 SiBiono Business Overview
10.14.5 SiBiono Recent Developments
11 CGT DRUGS MARKET FORECAST BY REGION
11.1 Global CGT Drugs Market Size Forecast
11.2 Global CGT Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CGT Drugs Market Size Forecast by Country
11.2.3 Asia Pacific CGT Drugs Market Size Forecast by Region
11.2.4 South America CGT Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CGT Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CGT Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CGT Drugs by Type (2026-2035)
12.1.2 Global CGT Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CGT Drugs by Type (2026-2035)
12.2 Global CGT Drugs Market Forecast by Application (2026-2035)
12.2.1 Global CGT Drugs Sales (K MT) Forecast by Application
12.2.2 Global CGT Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CGT Drugs
1.2 Key Market Segments
1.2.1 CGT Drugs Segment by Type
1.2.2 CGT Drugs Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CGT DRUGS MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CGT Drugs Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global CGT Drugs Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CGT DRUGS MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global CGT Drugs Product Life Cycle
3.3 Global CGT Drugs Sales by Manufacturers (2020-2025)
3.4 Global CGT Drugs Revenue Market Share by Manufacturers (2020-2025)
3.5 CGT Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global CGT Drugs Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 CGT Drugs Market Competitive Situation and Trends
3.8.1 CGT Drugs Market Concentration Rate
3.8.2 Global 5 and 10 Largest CGT Drugs Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 CGT DRUGS INDUSTRY CHAIN ANALYSIS
4.1 CGT Drugs Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CGT DRUGS MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global CGT Drugs Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to CGT Drugs Market
5.7 ESG Ratings of Leading Companies
6 CGT DRUGS MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CGT Drugs Sales Market Share by Type (2020-2025)
6.3 Global CGT Drugs Market Size by Type (2020-2025)
6.4 Global CGT Drugs Price by Type (2020-2025)
7 CGT DRUGS MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CGT Drugs Market Sales by Application (2020-2025)
7.3 Global CGT Drugs Market Size (M USD) by Application (2020-2025)
7.4 Global CGT Drugs Sales Growth Rate by Application (2020-2025)
8 CGT DRUGS MARKET SALES BY REGION
8.1 Global CGT Drugs Sales by Region
8.1.1 Global CGT Drugs Sales by Region
8.1.2 Global CGT Drugs Sales Market Share by Region
8.2 Global CGT Drugs Market Size by Region
8.2.1 Global CGT Drugs Market Size by Region
8.2.2 Global CGT Drugs Market Size by Region
8.3 North America
8.3.1 North America CGT Drugs Sales by Country
8.3.2 North America CGT Drugs Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe CGT Drugs Sales by Country
8.4.2 Europe CGT Drugs Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific CGT Drugs Sales by Region
8.5.2 Asia Pacific CGT Drugs Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America CGT Drugs Sales by Country
8.6.2 South America CGT Drugs Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa CGT Drugs Sales by Region
8.7.2 Middle East and Africa CGT Drugs Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 CGT DRUGS MARKET PRODUCTION BY REGION
9.1 Global Production of CGT Drugs by Region(2020-2025)
9.2 Global CGT Drugs Revenue Market Share by Region (2020-2025)
9.3 Global CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America CGT Drugs Production
9.4.1 North America CGT Drugs Production Growth Rate (2020-2025)
9.4.2 North America CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe CGT Drugs Production
9.5.1 Europe CGT Drugs Production Growth Rate (2020-2025)
9.5.2 Europe CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan CGT Drugs Production (2020-2025)
9.6.1 Japan CGT Drugs Production Growth Rate (2020-2025)
9.6.2 Japan CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China CGT Drugs Production (2020-2025)
9.7.1 China CGT Drugs Production Growth Rate (2020-2025)
9.7.2 China CGT Drugs Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Janssen Biotech
10.1.1 Janssen Biotech Basic Information
10.1.2 Janssen Biotech CGT Drugs Product Overview
10.1.3 Janssen Biotech CGT Drugs Product Market Performance
10.1.4 Janssen Biotech Business Overview
10.1.5 Janssen Biotech SWOT Analysis
10.1.6 Janssen Biotech Recent Developments
10.2 Celgene Corporation
10.2.1 Celgene Corporation Basic Information
10.2.2 Celgene Corporation CGT Drugs Product Overview
10.2.3 Celgene Corporation CGT Drugs Product Market Performance
10.2.4 Celgene Corporation Business Overview
10.2.5 Celgene Corporation SWOT Analysis
10.2.6 Celgene Corporation Recent Developments
10.3 Juno Therapeutics
10.3.1 Juno Therapeutics Basic Information
10.3.2 Juno Therapeutics CGT Drugs Product Overview
10.3.3 Juno Therapeutics CGT Drugs Product Market Performance
10.3.4 Juno Therapeutics Business Overview
10.3.5 Juno Therapeutics SWOT Analysis
10.3.6 Juno Therapeutics Recent Developments
10.4 Kite Pharma
10.4.1 Kite Pharma Basic Information
10.4.2 Kite Pharma CGT Drugs Product Overview
10.4.3 Kite Pharma CGT Drugs Product Market Performance
10.4.4 Kite Pharma Business Overview
10.4.5 Kite Pharma Recent Developments
10.5 Novartis
10.5.1 Novartis Basic Information
10.5.2 Novartis CGT Drugs Product Overview
10.5.3 Novartis CGT Drugs Product Market Performance
10.5.4 Novartis Business Overview
10.5.5 Novartis Recent Developments
10.6 Spark Therapeutics
10.6.1 Spark Therapeutics Basic Information
10.6.2 Spark Therapeutics CGT Drugs Product Overview
10.6.3 Spark Therapeutics CGT Drugs Product Market Performance
10.6.4 Spark Therapeutics Business Overview
10.6.5 Spark Therapeutics Recent Developments
10.7 Amgen
10.7.1 Amgen Basic Information
10.7.2 Amgen CGT Drugs Product Overview
10.7.3 Amgen CGT Drugs Product Market Performance
10.7.4 Amgen Business Overview
10.7.5 Amgen Recent Developments
10.8 Bluebird Bio
10.8.1 Bluebird Bio Basic Information
10.8.2 Bluebird Bio CGT Drugs Product Overview
10.8.3 Bluebird Bio CGT Drugs Product Market Performance
10.8.4 Bluebird Bio Business Overview
10.8.5 Bluebird Bio Recent Developments
10.9 GSK
10.9.1 GSK Basic Information
10.9.2 GSK CGT Drugs Product Overview
10.9.3 GSK CGT Drugs Product Market Performance
10.9.4 GSK Business Overview
10.9.5 GSK Recent Developments
10.10 Orchard Therapeutics
10.10.1 Orchard Therapeutics Basic Information
10.10.2 Orchard Therapeutics CGT Drugs Product Overview
10.10.3 Orchard Therapeutics CGT Drugs Product Market Performance
10.10.4 Orchard Therapeutics Business Overview
10.10.5 Orchard Therapeutics Recent Developments
10.11 Sequoia
10.11.1 Sequoia Basic Information
10.11.2 Sequoia CGT Drugs Product Overview
10.11.3 Sequoia CGT Drugs Product Market Performance
10.11.4 Sequoia Business Overview
10.11.5 Sequoia Recent Developments
10.12 Fosun Kite Biotechnology
10.12.1 Fosun Kite Biotechnology Basic Information
10.12.2 Fosun Kite Biotechnology CGT Drugs Product Overview
10.12.3 Fosun Kite Biotechnology CGT Drugs Product Market Performance
10.12.4 Fosun Kite Biotechnology Business Overview
10.12.5 Fosun Kite Biotechnology Recent Developments
10.13 Sunway Biotech
10.13.1 Sunway Biotech Basic Information
10.13.2 Sunway Biotech CGT Drugs Product Overview
10.13.3 Sunway Biotech CGT Drugs Product Market Performance
10.13.4 Sunway Biotech Business Overview
10.13.5 Sunway Biotech Recent Developments
10.14 SiBiono
10.14.1 SiBiono Basic Information
10.14.2 SiBiono CGT Drugs Product Overview
10.14.3 SiBiono CGT Drugs Product Market Performance
10.14.4 SiBiono Business Overview
10.14.5 SiBiono Recent Developments
11 CGT DRUGS MARKET FORECAST BY REGION
11.1 Global CGT Drugs Market Size Forecast
11.2 Global CGT Drugs Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe CGT Drugs Market Size Forecast by Country
11.2.3 Asia Pacific CGT Drugs Market Size Forecast by Region
11.2.4 South America CGT Drugs Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of CGT Drugs by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global CGT Drugs Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of CGT Drugs by Type (2026-2035)
12.1.2 Global CGT Drugs Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of CGT Drugs by Type (2026-2035)
12.2 Global CGT Drugs Market Forecast by Application (2026-2035)
12.2.1 Global CGT Drugs Sales (K MT) Forecast by Application
12.2.2 Global CGT Drugs Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CGT Drugs Market Size by Type (M USD)
Table 4. Global CGT Drugs Market Size by Application
Table 5. CGT Drugs Market Size Comparison by Region (M USD)
Table 6. Global CGT Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CGT Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CGT Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CGT Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT Drugs as of 2025)
Table 11. Global Market CGT Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CGT Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CGT Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CGT Drugs Sales by Type (K MT)
Table 27. Global CGT Drugs Market Size by Type (M USD)
Table 28. Global CGT Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global CGT Drugs Sales Market Share by Type (2020-2025)
Table 30. Global CGT Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global CGT Drugs Market Share by Type (2020-2025)
Table 32. Global CGT Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global CGT Drugs Sales (K MT) by Application
Table 34. Global CGT Drugs Market Size by Application
Table 35. Global CGT Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global CGT Drugs Sales Market Share by Application (2020-2025)
Table 37. Global CGT Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global CGT Drugs Market Share by Application (2020-2025)
Table 39. Global CGT Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global CGT Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global CGT Drugs Sales Market Share by Region (2020-2025)
Table 42. Global CGT Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global CGT Drugs Market Size by Region (2020-2025)
Table 44. North America CGT Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America CGT Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CGT Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe CGT Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CGT Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CGT Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America CGT Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America CGT Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CGT Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CGT Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global CGT Drugs Production (K MT) by Region(2020-2025)
Table 55. Global CGT Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CGT Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Janssen Biotech Basic Information
Table 63. Janssen Biotech CGT Drugs Product Overview
Table 64. Janssen Biotech CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Janssen Biotech Business Overview
Table 66. Janssen Biotech SWOT Analysis
Table 67. Janssen Biotech Recent Developments
Table 68. Celgene Corporation Basic Information
Table 69. Celgene Corporation CGT Drugs Product Overview
Table 70. Celgene Corporation CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Celgene Corporation Business Overview
Table 72. Celgene Corporation SWOT Analysis
Table 73. Celgene Corporation Recent Developments
Table 74. Juno Therapeutics Basic Information
Table 75. Juno Therapeutics CGT Drugs Product Overview
Table 76. Juno Therapeutics CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Juno Therapeutics Business Overview
Table 78. Juno Therapeutics SWOT Analysis
Table 79. Juno Therapeutics Recent Developments
Table 80. Kite Pharma Basic Information
Table 81. Kite Pharma CGT Drugs Product Overview
Table 82. Kite Pharma CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Kite Pharma Business Overview
Table 84. Kite Pharma Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis CGT Drugs Product Overview
Table 87. Novartis CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Spark Therapeutics Basic Information
Table 91. Spark Therapeutics CGT Drugs Product Overview
Table 92. Spark Therapeutics CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Spark Therapeutics Business Overview
Table 94. Spark Therapeutics Recent Developments
Table 95. Amgen Basic Information
Table 96. Amgen CGT Drugs Product Overview
Table 97. Amgen CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Amgen Business Overview
Table 99. Amgen Recent Developments
Table 100. Bluebird Bio Basic Information
Table 101. Bluebird Bio CGT Drugs Product Overview
Table 102. Bluebird Bio CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bluebird Bio Business Overview
Table 104. Bluebird Bio Recent Developments
Table 105. GSK Basic Information
Table 106. GSK CGT Drugs Product Overview
Table 107. GSK CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GSK Business Overview
Table 109. GSK Recent Developments
Table 110. Orchard Therapeutics Basic Information
Table 111. Orchard Therapeutics CGT Drugs Product Overview
Table 112. Orchard Therapeutics CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Orchard Therapeutics Business Overview
Table 114. Orchard Therapeutics Recent Developments
Table 115. Sequoia Basic Information
Table 116. Sequoia CGT Drugs Product Overview
Table 117. Sequoia CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sequoia Business Overview
Table 119. Sequoia Recent Developments
Table 120. Fosun Kite Biotechnology Basic Information
Table 121. Fosun Kite Biotechnology CGT Drugs Product Overview
Table 122. Fosun Kite Biotechnology CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Fosun Kite Biotechnology Business Overview
Table 124. Fosun Kite Biotechnology Recent Developments
Table 125. Sunway Biotech Basic Information
Table 126. Sunway Biotech CGT Drugs Product Overview
Table 127. Sunway Biotech CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Sunway Biotech Business Overview
Table 129. Sunway Biotech Recent Developments
Table 130. SiBiono Basic Information
Table 131. SiBiono CGT Drugs Product Overview
Table 132. SiBiono CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. SiBiono Business Overview
Table 134. SiBiono Recent Developments
Table 135. Global CGT Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global CGT Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America CGT Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe CGT Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific CGT Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific CGT Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America CGT Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa CGT Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global CGT Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global CGT Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global CGT Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global CGT Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global CGT Drugs Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global CGT Drugs Market Size by Type (M USD)
Table 4. Global CGT Drugs Market Size by Application
Table 5. CGT Drugs Market Size Comparison by Region (M USD)
Table 6. Global CGT Drugs Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global CGT Drugs Sales Market Share by Manufacturers (2020-2025)
Table 8. Global CGT Drugs Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global CGT Drugs Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT Drugs as of 2025)
Table 11. Global Market CGT Drugs Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global CGT Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CGT Drugs Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global CGT Drugs Sales by Type (K MT)
Table 27. Global CGT Drugs Market Size by Type (M USD)
Table 28. Global CGT Drugs Sales (K MT) by Type (2020-2025)
Table 29. Global CGT Drugs Sales Market Share by Type (2020-2025)
Table 30. Global CGT Drugs Market Size (M USD) by Type (2020-2025)
Table 31. Global CGT Drugs Market Share by Type (2020-2025)
Table 32. Global CGT Drugs Price (USD/KG) by Type (2020-2025)
Table 33. Global CGT Drugs Sales (K MT) by Application
Table 34. Global CGT Drugs Market Size by Application
Table 35. Global CGT Drugs Sales by Application (2020-2025) & (K MT)
Table 36. Global CGT Drugs Sales Market Share by Application (2020-2025)
Table 37. Global CGT Drugs Market Size by Application (2020-2025) & (M USD)
Table 38. Global CGT Drugs Market Share by Application (2020-2025)
Table 39. Global CGT Drugs Sales Growth Rate by Application (2020-2025)
Table 40. Global CGT Drugs Sales by Region (2020-2025) & (K MT)
Table 41. Global CGT Drugs Sales Market Share by Region (2020-2025)
Table 42. Global CGT Drugs Market Size by Region (2020-2025) & (M USD)
Table 43. Global CGT Drugs Market Size by Region (2020-2025)
Table 44. North America CGT Drugs Sales by Country (2020-2025) & (K MT)
Table 45. North America CGT Drugs Market Size by Country (2020-2025) & (M USD)
Table 46. Europe CGT Drugs Sales by Country (2020-2025) & (K MT)
Table 47. Europe CGT Drugs Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific CGT Drugs Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific CGT Drugs Market Size by Region (2020-2025) & (M USD)
Table 50. South America CGT Drugs Sales by Country (2020-2025) & (K MT)
Table 51. South America CGT Drugs Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa CGT Drugs Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa CGT Drugs Market Size by Region (2020-2025) & (M USD)
Table 54. Global CGT Drugs Production (K MT) by Region(2020-2025)
Table 55. Global CGT Drugs Revenue (US$ Million) by Region (2020-2025)
Table 56. Global CGT Drugs Revenue Market Share by Region (2020-2025)
Table 57. Global CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China CGT Drugs Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Janssen Biotech Basic Information
Table 63. Janssen Biotech CGT Drugs Product Overview
Table 64. Janssen Biotech CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Janssen Biotech Business Overview
Table 66. Janssen Biotech SWOT Analysis
Table 67. Janssen Biotech Recent Developments
Table 68. Celgene Corporation Basic Information
Table 69. Celgene Corporation CGT Drugs Product Overview
Table 70. Celgene Corporation CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Celgene Corporation Business Overview
Table 72. Celgene Corporation SWOT Analysis
Table 73. Celgene Corporation Recent Developments
Table 74. Juno Therapeutics Basic Information
Table 75. Juno Therapeutics CGT Drugs Product Overview
Table 76. Juno Therapeutics CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Juno Therapeutics Business Overview
Table 78. Juno Therapeutics SWOT Analysis
Table 79. Juno Therapeutics Recent Developments
Table 80. Kite Pharma Basic Information
Table 81. Kite Pharma CGT Drugs Product Overview
Table 82. Kite Pharma CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Kite Pharma Business Overview
Table 84. Kite Pharma Recent Developments
Table 85. Novartis Basic Information
Table 86. Novartis CGT Drugs Product Overview
Table 87. Novartis CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Novartis Business Overview
Table 89. Novartis Recent Developments
Table 90. Spark Therapeutics Basic Information
Table 91. Spark Therapeutics CGT Drugs Product Overview
Table 92. Spark Therapeutics CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Spark Therapeutics Business Overview
Table 94. Spark Therapeutics Recent Developments
Table 95. Amgen Basic Information
Table 96. Amgen CGT Drugs Product Overview
Table 97. Amgen CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Amgen Business Overview
Table 99. Amgen Recent Developments
Table 100. Bluebird Bio Basic Information
Table 101. Bluebird Bio CGT Drugs Product Overview
Table 102. Bluebird Bio CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. Bluebird Bio Business Overview
Table 104. Bluebird Bio Recent Developments
Table 105. GSK Basic Information
Table 106. GSK CGT Drugs Product Overview
Table 107. GSK CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. GSK Business Overview
Table 109. GSK Recent Developments
Table 110. Orchard Therapeutics Basic Information
Table 111. Orchard Therapeutics CGT Drugs Product Overview
Table 112. Orchard Therapeutics CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. Orchard Therapeutics Business Overview
Table 114. Orchard Therapeutics Recent Developments
Table 115. Sequoia Basic Information
Table 116. Sequoia CGT Drugs Product Overview
Table 117. Sequoia CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Sequoia Business Overview
Table 119. Sequoia Recent Developments
Table 120. Fosun Kite Biotechnology Basic Information
Table 121. Fosun Kite Biotechnology CGT Drugs Product Overview
Table 122. Fosun Kite Biotechnology CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Fosun Kite Biotechnology Business Overview
Table 124. Fosun Kite Biotechnology Recent Developments
Table 125. Sunway Biotech Basic Information
Table 126. Sunway Biotech CGT Drugs Product Overview
Table 127. Sunway Biotech CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Sunway Biotech Business Overview
Table 129. Sunway Biotech Recent Developments
Table 130. SiBiono Basic Information
Table 131. SiBiono CGT Drugs Product Overview
Table 132. SiBiono CGT Drugs Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. SiBiono Business Overview
Table 134. SiBiono Recent Developments
Table 135. Global CGT Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global CGT Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America CGT Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe CGT Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific CGT Drugs Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific CGT Drugs Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America CGT Drugs Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa CGT Drugs Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa CGT Drugs Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global CGT Drugs Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global CGT Drugs Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global CGT Drugs Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global CGT Drugs Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global CGT Drugs Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CGT Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CGT Drugs Market Size (M USD), 2025-2035
Figure 5. Global CGT Drugs Market Size (M USD) (2020-2035)
Figure 6. Global CGT Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CGT Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CGT Drugs Product Life Cycle
Figure 13. CGT Drugs Sales Share by Manufacturers in 2025
Figure 14. Global CGT Drugs Revenue Share by Manufacturers in 2025
Figure 15. CGT Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CGT Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CGT Drugs Revenue in 2025
Figure 18. Industry Chain Map of CGT Drugs
Figure 19. Global CGT Drugs Market PEST Analysis
Figure 20. Global CGT Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CGT Drugs Market Share by Type
Figure 27. Sales Market Share of CGT Drugs by Type (2020-2025)
Figure 28. Sales Market Share of CGT Drugs by Type in 2025
Figure 29. Market Share of CGT Drugs by Type (2020-2025)
Figure 30. Market Share of CGT Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CGT Drugs Market Share by Application
Figure 33. Global CGT Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global CGT Drugs Sales Market Share by Application in 2025
Figure 35. Global CGT Drugs Market Share by Application (2020-2025)
Figure 36. Global CGT Drugs Market Share by Application in 2025
Figure 37. Global CGT Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global CGT Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global CGT Drugs Market Size by Region (2020-2025)
Figure 40. North America CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CGT Drugs Sales Market Share by Country in 2024
Figure 43. North America CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CGT Drugs Market Size by Country in 2024
Figure 45. U.S. CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CGT Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CGT Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CGT Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CGT Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CGT Drugs Sales Market Share by Country in 2024
Figure 53. Europe CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CGT Drugs Market Size by Country in 2024
Figure 55. Germany CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CGT Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CGT Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific CGT Drugs Market Size by Region in 2024
Figure 68. China CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CGT Drugs Sales and Growth Rate (K MT)
Figure 79. South America CGT Drugs Sales Market Share by Country in 2024
Figure 80. South America CGT Drugs Market Size and Growth Rate (M USD)
Figure 81. South America CGT Drugs Market Size by Country in 2024
Figure 82. Brazil CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CGT Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CGT Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CGT Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CGT Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CGT Drugs Production Market Share by Region (2020-2025)
Figure 103. North America CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CGT Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CGT Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CGT Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CGT Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global CGT Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global CGT Drugs Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of CGT Drugs
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CGT Drugs Market Size (M USD), 2025-2035
Figure 5. Global CGT Drugs Market Size (M USD) (2020-2035)
Figure 6. Global CGT Drugs Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CGT Drugs Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global CGT Drugs Product Life Cycle
Figure 13. CGT Drugs Sales Share by Manufacturers in 2025
Figure 14. Global CGT Drugs Revenue Share by Manufacturers in 2025
Figure 15. CGT Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market CGT Drugs Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by CGT Drugs Revenue in 2025
Figure 18. Industry Chain Map of CGT Drugs
Figure 19. Global CGT Drugs Market PEST Analysis
Figure 20. Global CGT Drugs Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global CGT Drugs Market Share by Type
Figure 27. Sales Market Share of CGT Drugs by Type (2020-2025)
Figure 28. Sales Market Share of CGT Drugs by Type in 2025
Figure 29. Market Share of CGT Drugs by Type (2020-2025)
Figure 30. Market Share of CGT Drugs by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global CGT Drugs Market Share by Application
Figure 33. Global CGT Drugs Sales Market Share by Application (2020-2025)
Figure 34. Global CGT Drugs Sales Market Share by Application in 2025
Figure 35. Global CGT Drugs Market Share by Application (2020-2025)
Figure 36. Global CGT Drugs Market Share by Application in 2025
Figure 37. Global CGT Drugs Sales Growth Rate by Application (2020-2025)
Figure 38. Global CGT Drugs Sales Market Share by Region (2020-2025)
Figure 39. Global CGT Drugs Market Size by Region (2020-2025)
Figure 40. North America CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America CGT Drugs Sales Market Share by Country in 2024
Figure 43. North America CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America CGT Drugs Market Size by Country in 2024
Figure 45. U.S. CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada CGT Drugs Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada CGT Drugs Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico CGT Drugs Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico CGT Drugs Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe CGT Drugs Sales Market Share by Country in 2024
Figure 53. Europe CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe CGT Drugs Market Size by Country in 2024
Figure 55. Germany CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific CGT Drugs Sales and Growth Rate (K MT)
Figure 66. Asia Pacific CGT Drugs Sales Market Share by Region in 2024
Figure 67. Asia Pacific CGT Drugs Market Size by Region in 2024
Figure 68. China CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America CGT Drugs Sales and Growth Rate (K MT)
Figure 79. South America CGT Drugs Sales Market Share by Country in 2024
Figure 80. South America CGT Drugs Market Size and Growth Rate (M USD)
Figure 81. South America CGT Drugs Market Size by Country in 2024
Figure 82. Brazil CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa CGT Drugs Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa CGT Drugs Sales Market Share by Region in 2024
Figure 90. Middle East and Africa CGT Drugs Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa CGT Drugs Market Size by Region in 2024
Figure 92. Saudi Arabia CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa CGT Drugs Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa CGT Drugs Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global CGT Drugs Production Market Share by Region (2020-2025)
Figure 103. North America CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 106. China CGT Drugs Production (K MT) Growth Rate (2020-2025)
Figure 107. Global CGT Drugs Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global CGT Drugs Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global CGT Drugs Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global CGT Drugs Market Share Forecast by Type (2026-2035)
Figure 111. Global CGT Drugs Sales Forecast by Application (2026-2035)
Figure 112. Global CGT Drugs Market Share Forecast by Application (2026-2035)
